Regis Corporation Form 4 shows new 2,727-share director grant

Rhea-AI Filing Summary

Regis Corporation (RGS) reported an equity grant to one of its directors. On November 14, 2025, the director acquired 2,727 shares of common stock at a price of $0, increasing the director’s beneficial ownership to 8,114 shares, held directly. This was reported on a Form 4 filed for a single reporting person.

The shares were granted as an equity award that vests on the earlier of November 14, 2026 or the company’s next annual meeting of shareholders after November 14, 2025, provided the director continues to serve on the board and meets the other terms of the grant agreements. This reflects routine director compensation in stock rather than a market purchase.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MANSBACH MICHAEL JOSEPH

(Last) (First) (Middle)

3701 WAYZATA BLVD

(Street)

MINNEAPOLIS MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIS CORP [ RGS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/14/2025		A		2,727(1)	A	$0	8,114	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The award vests on the earlier of November 14, 2026 or the Issuer's next annual meeting of shareholders after November 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date and the other terms and conditions of the grant agreements.

	/s/ Amy C. Seidel, by power of attorney	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Regis Corporation (RGS) report in this Form 4?

Regis Corporation reported that a director received an equity grant of 2,727 shares of common stock on November 14, 2025, at a price of $0 per share.

How many Regis (RGS) shares does the director beneficially own after this grant?

Following the reported transaction, the director beneficially owns 8,114 shares of Regis common stock, held in direct ownership.

What are the vesting conditions for the 2,727-share award at Regis (RGS)?

The 2,727-share award vests on the earlier of November 14, 2026 or Regis’s next annual meeting of shareholders after November 14, 2025, subject to the director’s continued service and other grant terms.

Was the Regis (RGS) director stock award a purchase on the open market?

No. The Form 4 shows the transaction code as an acquisition at a price of $0, indicating it was an equity grant rather than an open-market purchase.

What is the reporting person’s relationship to Regis Corporation (RGS)?

The reporting person is identified as a Director of Regis Corporation and filed the Form 4 as a single reporting person.

When will the Regis (RGS) director award fully vest if the annual meeting occurs earlier?

The award will vest at the earlier of November 14, 2026 or the company’s next annual shareholder meeting after November 14, 2025, assuming continued service to the company through that date.